TOP TIERMARKET NEWSWIRE
News & sentiment

ALNYLAM PHARMACEUTIC (ALNY) — News & AI sentiment

ALNYLAM PHARMACEUTIC (ALNY) news roundup. 3 stories in the past week, 33 over 30 days. Average 30-day sentiment is 52.8/100. No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 2 purchases (~$16K) and 4 sales (~$57K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 51.7/100
30d stories
33
avg sentiment 52.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
-2
2 buys · 4 sells

ALNY news in the last 24 hours, 7 days, 30 days and 90 days

How much ALNY coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowALNY storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days351.7/100ALNY headlines →
Last 30 days3352.8/100ALNY headlines →
Last 90 days7553.9/100ALNY headlines →

Latest stories on ALNY

3d ago
5d ago
5d ago
Sep 2
H.C. Wainwright reiterates Alnylam stock rating on drug differentiation
Investing.com Analyst Ratings56 · neutralanalyst
Sep 2
Stifel reiterates Buy rating on Alnylam stock after ESC data
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Alnylam stock maintained at Buy by TD Cowen on silencing data
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Alnylam stock maintained at Buy by Truist on mixed trial data
Investing.com Analyst Ratings56 · neutralanalyst
Aug 31
BMO reiterates Alnylam stock Outperform on ATTR franchise strength
Investing.com Analyst Ratings63 · neutralanalyst
Aug 31
Canaccord reiterates Alnylam stock Buy rating after cardiology data
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 30
Aug 30
Aug 30
Aug 28
Aug 28
Why is Alnylam Pharmaceuticals stock sliding today?
Investing.com Markets34 · bearishgeneral
Aug 28
Alnylam Pharmaceuticals stock falls on silencer drug concerns
Investing.com Markets38 · neutralgeneral
Aug 28
Aug 27
Bernstein reiterates Alnylam stock rating on nucresiran outlook
Investing.com Analyst Ratings56 · neutralanalyst
Aug 25
Aug 24
Aug 24
Aug 22
Aug 20
Aug 20
Aug 20
Open ALNY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →